Takenobu T, Tomizawa K, Matsushita M, Li ST, Moriwaki, A. Lu YF. Matsui H (2002)
Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.
Mol Cancer Ther 1: 1043 -1049.
Li ST, Kato K, Tomizawa K, Matsushita M, Moriwaki A, Matsui H. Mikoshiba K (2002)
Calcineurin plays different roles in group II metabotropic glutamate-and NMDA receptor-dependent long-term depression.
J Neurosci 22: 5034-5041.
Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui, H (2002)
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
J Neurosci 22: 2590-2597.
Hanashiro K, Tokeshi Y, Nakasone T, Sunagawa M, Nakamura M and Kosugi T (2002) Azelastine and suplatast shorten the distribution half-life of IgE in rats.
Mediat Inflamm 11: 61-64.
Kinjoh K, Nakamura M, Zeng G, and Kosugi T (2002) An antibody that binds to primary specific pocket-associated structure in the active site of bovine thrombin.
Hybridoma and hybridomics 21: 61-67.
Nakasone T, Hanashiro K, Nakamura M, Sunakawa H, Kosugi T (2002) Mast cell-derived VEGF enhances the passage of IgE FE-3 through the rat aortic endothelial cell monolayer.
Int Arch Allergy Immunol 129:76-85.
Kinjoh K, Nakamura M, Zeng G, Sunagawa M, Eguchi Y, Kosugi T (2002) Bound thrombin from crushed clots is composed of a-thrombin and the N-Terminal regions of a-and g-chains of fibrinogen.
Pathophysiol Haemost Thromb 32: 165-173.
Kinjoh K, Nakamura M, Sunagawa M, Kosugi T (2002) Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
Haematologia 32: 457-465.
琉大医学部コンテンツ
